IRIS wins rights to Sysmex urine cell analyser:
This article was originally published in Clinica
International Remote Imaging Systems (IRIS) has been awarded exclusive rights to Toa Medical Electronics' Sysmex UF-100 urine cell analyser in North America. The distributorship is the result of an arbitration proceeding following litigation between the two companies. The Paris-based International Chamber of Commerce Court also ruled that Toa must pay IRIS royalties on sales of the product in other parts of the world.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.